Aemetis, Inc. (NASDAQ:AMTX) Given Average Rating of "Moderate Buy" by Analysts

Shares of Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $12.95.

A number of equities research analysts have recently issued reports on the stock. StockNews.com raised shares of Aemetis to a "sell" rating in a research report on Friday. HC Wainwright restated a "buy" rating and issued a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd.

Aemetis Price Performance

Aemetis stock traded up $0.02 during mid-day trading on Monday, reaching $2.99. 601,878 shares of the stock traded hands, compared to its average volume of 671,145. The stock has a market capitalization of $148.71 million, a PE ratio of -1.32 and a beta of 1.47. The business's 50-day moving average is $3.27 and its 200-day moving average is $2.97. Aemetis has a 12-month low of $2.10 and a 12-month high of $7.03.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter last year, the company earned ($0.59) EPS. Equities analysts anticipate that Aemetis will post -2.02 EPS for the current fiscal year.

Institutional Investors Weigh In On Aemetis

A number of institutional investors and hedge funds have recently bought and sold shares of the business. FMR LLC grew its position in shares of Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company's stock worth $52,000 after purchasing an additional 9,137 shares in the last quarter. Hutchinson Capital Management CA purchased a new stake in Aemetis during the 2nd quarter valued at approximately $70,000. Barclays PLC raised its position in shares of Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company's stock valued at $109,000 after buying an additional 34,816 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company's stock worth $157,000 after buying an additional 50,528 shares in the last quarter. Finally, Wellington Management Group LLP purchased a new position in shares of Aemetis in the third quarter worth $177,000. 27.02% of the stock is owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.